Medicines as a Service
The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services that improve access and adherence to prescription drugs for common chronic conditions. Such innovation beyond drug development is consistent with the...
Gardado en:
| Main Authors: | , , |
|---|---|
| Formato: | Online |
| Idioma: | inglés |
| Publicado: |
RAND Corporation
2023
|
| Subjects: | |
| Acceso en liña: | ONIX_20231005_9780833076465_783 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
| Summary: | The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services that improve access and adherence to prescription drugs for common chronic conditions. Such innovation beyond drug development is consistent with the core capabilities of large pharmaceutical companies and has the potential to achieve profit levels similar to those of its traditional models. |
|---|